The motivations and methodology for high-throughput PET imaging of small animals in cancer research

被引:12
作者
Aide, Nicolas [1 ,2 ]
Visser, Eric P. [3 ]
Lheureux, Stephanie [2 ,4 ]
Heutte, Natacha [4 ]
Szanda, Istvan [5 ]
Hicks, Rodney J. [6 ]
机构
[1] Francois Baclesse Canc Ctr, Dept Nucl Med, F-14076 Caen, France
[2] Univ Caen, BioTICLA Team, EA 4656, IFR 146, F-14032 Caen, France
[3] Radboud Univ Nijmegen, Med Ctr, Dept Nucl Med, NL-6525 ED Nijmegen, Netherlands
[4] Francois Baclesse Canc Ctr, Clin Res Unit, Caen, France
[5] Kings Coll London, Div Imaging Sci & Biomed Engn, London WC2R 2LS, England
[6] Peter MacCallum Canc Ctr, Ctr Mol Imaging, Melbourne, Australia
关键词
High throughput; Sample size; Clinical PET/CT; Small-animal PET; Planar positron imaging systems; NEMA NU 4; Animal models; POSITRON-EMISSION-TOMOGRAPHY; MAXIMUM A-POSTERIORI; PERFORMANCE EVALUATION; CLINICAL-TRIALS; IN-VIVO; TUMOR XENOGRAFTS; SURROGATE MARKER; BLOOD-GLUCOSE; SYSTEM PPIS; SCANNER;
D O I
10.1007/s00259-012-2177-x
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Over the last decade, small-animal PET imaging has become a vital platform technology in cancer research. With the development of molecularly targeted therapies and drug combinations requiring evaluation of different schedules, the number of animals to be imaged within a PET experiment has increased. This paper describes experimental design requirements to reach statistical significance, based on the expected change in tracer uptake in treated animals as compared to the control group, the number of groups that will be imaged, and the expected intra-animal variability for a given tracer. We also review how high-throughput studies can be performed in dedicated small-animal PET, high-resolution clinical PET systems and planar positron imaging systems by imaging more than one animal simultaneously. Customized beds designed to image more than one animal in large-bore small-animal PET scanners are described. Physics issues related to the presence of several rodents within the field of view (i.e. deterioration of spatial resolution and sensitivity as the radial and the axial offsets increase, respectively, as well as a larger effect of attenuation and the number of scatter events), which can be assessed by using the NEMA NU 4 image quality phantom, are detailed.
引用
收藏
页码:1497 / 1509
页数:13
相关论文
共 53 条
[1]   What is the right dose? The elusive optimal biologic dose in phase I clinical trials [J].
Adjei, Alex A. .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (25) :4054-4055
[2]   A Dual Radiologic Contrast Agent Protocol for 18F-FDG and 18F-FLT PET/CT Imaging of Mice Bearing Abdominal Tumors [J].
Aide, Nicolas ;
Kinross, Kathryn ;
Beauregard, Jean-Mathieu ;
Neels, Oliver ;
Potdevin, Titaina ;
Roselt, Peter ;
Dorow, Donna ;
Cullinane, Carleen ;
Hicks, Rodney J. .
MOLECULAR IMAGING AND BIOLOGY, 2011, 13 (03) :518-525
[3]   18F-FLT PET as a Surrogate Marker of Drug Efficacy During mTOR Inhibition by Everolimus in a Preclinical Cisplatin-Resistant Ovarian Tumor Model [J].
Aide, Nicolas ;
Kinross, Kathryn ;
Cullinane, Carleen ;
Roselt, Peter ;
Waldeck, Kelly ;
Neels, Oliver ;
Dorow, Donna ;
McArthur, Grant ;
Hicks, Rodney J. .
JOURNAL OF NUCLEAR MEDICINE, 2010, 51 (10) :1559-1564
[4]   High-throughput small animal PET imaging in cancer research: evaluation of the capability of the Inveon scanner to image four mice simultaneously [J].
Aide, Nicolas ;
Desmonts, Cedric ;
Briand, Melanie ;
Meryet-Figuiere, Mathieu ;
Poulain, Laurent .
NUCLEAR MEDICINE COMMUNICATIONS, 2010, 31 (10) :851-858
[5]   High throughput static and dynamic small animal imaging using clinical PET/CT: potential preclinical applications [J].
Aide, Nicolas ;
Desmonts, Cedric ;
Beauregard, Jean-Mathieu ;
Beyer, Thomas ;
Kinross, Kathryn ;
Roselt, Peter ;
Neels, Oliver ;
Agostini, Denis ;
Bardet, Stephane ;
Bouvard, Gerard ;
Hicks, Rodney J. .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 (05) :991-1001
[6]   Acquisition setting optimization and quantitative imaging for 124I studies with the Inveon microPET-CT system [J].
Anizan, Nadege ;
Carlier, Thomas ;
Hindorf, Cecilia ;
Barbet, Jacques ;
Bardies, Manuel .
EJNMMI RESEARCH, 2012, 2 :1-9
[7]   Performance Evaluation of the Inveon Dedicated PET Preclinical Tomograph Based on the NEMA NU-4 Standards [J].
Bao, Qinan ;
Newport, Danny ;
Chen, Mu ;
Stout, David B. ;
Chatziioannou, Arion F. .
JOURNAL OF NUCLEAR MEDICINE, 2009, 50 (03) :401-408
[8]   FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0 [J].
Boellaard, Ronald ;
O'Doherty, Mike J. ;
Weber, Wolfgang A. ;
Mottaghy, Felix M. ;
Lonsdale, Markus N. ;
Stroobants, Sigrid G. ;
Oyen, Wim J. G. ;
Kotzerke, Joerg ;
Hoekstra, Otto S. ;
Pruim, Jan ;
Marsden, Paul K. ;
Tatsch, Klaus ;
Hoekstra, Corneline J. ;
Visser, Eric P. ;
Arends, Bertjan ;
Verzijlbergen, Fred J. ;
Zijlstra, Josee M. ;
Comans, Emile F. I. ;
Lammertsma, Adriaan A. ;
Paans, Anne M. ;
Willemsen, Antoon T. ;
Beyer, Thomas ;
Bockisch, Andreas ;
Schaefer-Prokop, Cornelia ;
Delbeke, Dominique ;
Baum, Richard P. ;
Chiti, Arturo ;
Krause, Bernd J. .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 (01) :181-200
[9]  
Brix G, 1997, EUR J NUCL MED, V24, P779
[10]   FDG uptake is a surrogate marker for defining the optimal biological dose of the mTOR inhibitor everolimus in vivo [J].
Cejka, D. ;
Kuntner, C. ;
Preusser, M. ;
Fritzer-Szekeres, M. ;
Fueger, B. J. ;
Strommer, S. ;
Werzowa, J. ;
Fuereder, T. ;
Wanek, T. ;
Zsebedics, M. ;
Mueller, M. ;
Langer, O. ;
Wacheck, V. .
BRITISH JOURNAL OF CANCER, 2009, 100 (11) :1739-1745